LATAM Daily Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.

Press releases published on June 2, 2026

Jun. 2, 2026

Orano מגדילה את הבעלות במכרה Cigar Lake בקנדה

Indeterminate GlobeNewswire

Jun. 2, 2026

Orano Meningkatkan Kepemilikan di Tambang Cigar Lake di Kanada

Indeterminate GlobeNewswire

Jun. 2, 2026

오라노 (Orano), 캐나다 시가 레이크 우라늄 광산 지분 확대

Indeterminate GlobeNewswire

Jun. 2, 2026

オラノ、カナダのシガー・レイク鉱山の持分比率を引き上げ

Indeterminate GlobeNewswire

Jun. 2, 2026

Orano Meningkatkan Pemilikan dalam Lombong Cigar Lake di Kanada

Indeterminate GlobeNewswire

Jun. 2, 2026

Orano Aumenta Participação na Mina de Cigar Lake no Canadá

Indeterminate GlobeNewswire

Jun. 2, 2026

Orano เพิ่มสัดส่วนการถือครองหุ้นในเหมือง Cigar Lake ประเทศแคนาดา

Indeterminate GlobeNewswire

Jun. 2, 2026

Orano 增持加拿大 Cigar Lake 铀矿股权

Indeterminate GlobeNewswire

Jun. 2, 2026

Orano 增加在加拿大 Cigar Lake 礦場的持股比例

Indeterminate GlobeNewswire

Jun. 2, 2026

Critical Metals Corp. Provides Project Update on Acceleration Plan and Tanbreez Development Progress

Indeterminate GlobeNewswire

Jun. 2, 2026

Brookfield Renewable to Issue C$150 Million of 5.75% Preferred Units

Indeterminate GlobeNewswire

Jun. 2, 2026

Update on Globex’s Mont Sorcier Iron Royalty Asset

Indeterminate GlobeNewswire

Jun. 2, 2026

Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer

Indeterminate GlobeNewswire

Jun. 2, 2026

Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

Indeterminate GlobeNewswire

Jun. 2, 2026

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Indeterminate GlobeNewswire

Jun. 2, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure

Indeterminate GlobeNewswire

Jun. 2, 2026

Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome

Indeterminate GlobeNewswire

Jun. 2, 2026

UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution

Indeterminate GlobeNewswire

Jun. 2, 2026

ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia

Indeterminate GlobeNewswire

Jun. 2, 2026

ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026

Indeterminate GlobeNewswire